Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that ...
Organon and Henlius announce FDA approval of POHERDY, the first and only pertuzumab biosimilar in the US, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback